An Fc Double-Engineered CD20 Antibody with Enhanced Ability to Trigger Complement-Dependent Cytotoxicity and Antibody-Dependent Cell-Mediated Cytotoxicity

Publisher： Karger

E-ISSN： 1660-3818|44|5|292-300

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.44, Iss.5, 2017-09, pp. : 292-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vascular Endothelial Growth Factor Partially Inhibits the Trastuzumab-Mediated Antibody-Dependent Cellular Cytotoxicity of Human Monocytes

By  

Oncology, Vol. 72, Iss. 3-4, 2007-12 ,pp. : 172-180

Karger

Access to resources Recommend Favorite

Fc receptors in antibody‐dependent enhancement of viral infections

By  

IMMUNOLOGICAL REVIEWS (ELECTRONIC), Vol. 268, Iss. 1, 2015-11 ,pp. : 340-364

John Wiley & Sons Inc

Access to resources Recommend Favorite

MDX‐1097 induces antibody‐dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 3, 2015-05 ,pp. : 333-343

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic variation of human neutrophil Fcγ receptors and SIRPα in antibody‐dependent cellular cytotoxicity towards cancer cells

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 48, Iss. 2, 2018-02 ,pp. : 344-354

John Wiley & Sons Inc

Access to resources Recommend Favorite

Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody‐dependent cytotoxicity and improves overall survival against CD20+ rituximab‐sensitive/‐resistant Burkitt lymphoma (BL) and precursor B‐acute lymphoblastic leukaemia (pre‐B‐ALL): potential targeted therapy in patients with poor risk CD20+BL and pre‐B‐ALL

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 5, 2015-12 ,pp. : 763-775

John Wiley & Sons Inc

Access to resources Recommend Favorite